Latanoprostenbunod
Products Latanoprostenebunod was approved in the United States in 2017 in the form of eye drops (Vyzulta). Structure and properties Latanoprostenebunod is a prodrug that is metabolized in the eye to latanoprost acid and butanediol mononitrate. Butanediol mononitrate is further biotransformed to 1,4-butanediol and nitric oxide (NO). Latanoprost acid is also formed from latanoprost, which … Latanoprostenbunod
